CLOROTEKAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clorotekal, and what generic alternatives are available?
Clorotekal is a drug marketed by B Braun Medical Inc and is included in one NDA. There are two patents protecting this drug.
This drug has thirty-one patent family members in twenty-seven countries.
The generic ingredient in CLOROTEKAL is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clorotekal
A generic version of CLOROTEKAL was approved as chloroprocaine hydrochloride by HIKMA on September 9th, 1998.
Summary for CLOROTEKAL
| International Patents: | 31 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Clinical Trials: | 2 |
| Patent Applications: | 752 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CLOROTEKAL |
| What excipients (inactive ingredients) are in CLOROTEKAL? | CLOROTEKAL excipients list |
| DailyMed Link: | CLOROTEKAL at DailyMed |
Recent Clinical Trials for CLOROTEKAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oregon Health and Science University | Phase 4 |
| B. Braun Medical Inc. | Phase 4 |
| University of Alabama at Birmingham | Phase 2 |
Pharmacology for CLOROTEKAL
| Drug Class | Ester Local Anesthetic |
| Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for CLOROTEKAL
US Patents and Regulatory Information for CLOROTEKAL
CLOROTEKAL is protected by two US patents.
Patents protecting CLOROTEKAL
Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR INDUCING A REGIONAL ANAESTHESIA VIA INTRATHECAL ADMINISTRATION OF A PATENTED PRESERVATIVE FREE SOLUTION FOR INJECTION (WITH A SPECIFIC COMPOSITION, PH, OSMOLALITY AND DENSITY) CONTAINING 9-11 MG/ML CHLOROPROCAINE HCL
Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical Inc | CLOROTEKAL | chloroprocaine hydrochloride | SOLUTION;INTRATHECAL | 208791-001 | Sep 26, 2017 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| B Braun Medical Inc | CLOROTEKAL | chloroprocaine hydrochloride | SOLUTION;INTRATHECAL | 208791-001 | Sep 26, 2017 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CLOROTEKAL
See the table below for patents covering CLOROTEKAL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Poland | 1931304 | ⤷ Try a Trial | |
| Slovenia | 1931304 | ⤷ Try a Trial | |
| European Patent Office | 1931304 | NOUVELLE UTILISATION D'UNE COMPOSITION COMPRENANT DU CHLORHYDRATE DE CHLOROPROCAINE, UNE NOUVELLE COMPOSITION COMPRENANT DU CHLORHYDRATE DE CHLOROPROCAINE ET UN PROCEDE PERMETTANT DE LA FABRIQUER (NEW USE FOR A COMPOSITION COMPRISING CHLOROPROCAINE HCL, A NEW COMPOSITION COMPRISING CHLOROPROCAINE HCL AND A METHOD FOR ITS MANUFACTURE) | ⤷ Try a Trial |
| Cyprus | 1114743 | ⤷ Try a Trial | |
| China | 105283222 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
